FDA feedback is a great achievement. Maybe it was already priced in, Ie that it would be good feedback. What we really need now is the funding facet sorted. If we can get funds from an external party; then we will rip. The Issue is going to be, if we need to do a cap raise. Which I think given the finances, could well be a strong possibility. Really hope we can avoid a cap raise, if we can.
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM, page-62
-
- There are more pages in this discussion • 411 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $5.671K | 298.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 512798 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1050263 | 5 |
View Market Depth
| Last trade - 15.59pm 04/10/2024 (20 minute delay) ? |
| BIT (ASX) Chart |